Upstate Active Clinical Trials

Study Title:

CALGB 50801-Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I And Stage II Classical Hodgkin Lymphoma (HL)

What is the purpose of the study?

This phase II clinical trial is studying how well response-based therapy assessed by PET scan works in treating patients with bulky stage I and stage II Hodgkin lymphoma.

Upstate Institutional Review Board (IRB) Number:


Study/Protocol ID:

CALGB 50801

Study Phase:


Patient Age Group:


Principal Investigator:

Dorothy C Pan, MD

ClinicalTrials.Gov ID:


For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Deanna J Cogswell, LPN
Phone: 315-464-8237

Return to Previous Page || Search Again